Multi-country non-interventional study on the effectiveness and safety of Empagliflozin in adult patients with type 2 diabetes in Europe and Asia

First published 21/01/2019

Last updated 02/04/2024

EU PAS number:

EUPAS27606

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

1245-0195-protocol-v1-0-final

English (1.43 MB - PDF)View document

Updated protocol

1245-0195-protocol-v2-0-final

First published: 22/02/2024

English (1.12 MB - PDF)View document

Study results

Study results

1245.195 Synopsis

English (639.71 KB - PDF)View document

Study report

Other information